Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1/2
    3
    100%

    Phase Distribution

    0

    Early Stage

    3

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 1/2Combined phases
    3(100.0%)

    Highest Phase Reached

    Phase 1/2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 1/2

    Trials by Phase

    Phase 1/23 (100.0%)

    Trials by Status

    completed267%
    unknown133%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completedphase_1_2

    Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus

    NCT00767260
    unknownphase_1_2

    Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

    NCT01883661
    completedphase_1_2

    Autologous Bone Marrow Stem Cells in Cirrhosis Patients

    NCT00713934

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT00767260Phase 1/2

    Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus

    Completed
    NCT01883661Phase 1/2

    Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

    Unknown
    NCT00713934Phase 1/2

    Autologous Bone Marrow Stem Cells in Cirrhosis Patients

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3